Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure
Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure Business Wire
Expansion brings
US FDA grants De Novo approval to Viz.ai's AI algorithm for hypertrophic cardiomyopathy
US FDA grants De Novo approval to Viz.ai's AI algorithm for hypertrophic cardiomyopathy unknown
Viz.ai, the
Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection
Viz.ai gets FDA De Novo approval for AI-enabled heart disease detection Andrea Fox
The U.S. Food and Drug
FDA Clears Viz.ai\'s AI Algorithm for Abdominal Aortic Aneurysm
FDA Clears Viz.ai\'s AI Algorithm for Abdominal Aortic Aneurysm sbrusco@rodmanmedia.com (Sam Brusco)
Viz.ai has
Viz.ai Appoints Radiology Advisory Board
Viz.ai Appoints Radiology Advisory Board mbarbella@rodmanmedia.com (Michael Barbella)
Viz.ai has created a Radiology Advisory Board to